Updates from Syncona and our portfolio companies
25.06.2018
Patients on Nightstar's clinical trial tell us about their experience with the diseases which causes blindness in males, and their hopes for Nightstar's potential treatment.
31.03.2017
Axumin, Blue Earth Diagnostics’ lead product, is an imaging agent used to detect the site of biochemical recurrence in prostate cancer patients, a significant unmet need.
